Healthcare
For more than 30 years, Alcimed has been supporting the leaders of the healthcare sector in their innovation and new market development projects.
Our activities for healthcare players
The explorers of Alcimed’s healthcare team support everyday pharmaceutical companies, biotechs, but also medical device, diagnostic, vaccine and animal health players in a wide variety of challenges linked to the healthcare sector: evolution of care pathways, innovative therapies, AI in healthcare, digitization of clinical trials, market access, and more.
They trust us
Some examples of projects carried out for our clients
Our projects cover diverse subjects such as new therapeutic technologies and approaches, preparing for new medication launches, understanding the management of diseases and care pathways, evaluating market opportunities and licensing, market access, regulatory evolution, and many more!
Learn more about our missions and expertise
Our missions
Our expertise
Our missions
Strategic marketing
Clients & Patients
R&D
Commercial strategy
Innovation
New partners
Strategy
Our expertise
Healthcare
Environment & Climate
Beauty & Nutrition
Energy & mobility
Sovereignty
Tech & data
What they say
-
"The benefit that really Alcimed brought to the table was to have an expert intermediary to take us through the process to really challenge our thinking."
Mark Twyman, Senior VP and Chief Commercial Officer at Inovio
Inovio Pharmaceuticals and Alcimed co-built a structured decision-making process to evaluate and prioritize therapeutic candidates in clinical development, drawing on a benchmark of industry best practices.
-
"Alcimed bring in some cross-industry views, which I just do not have the capacity to see myself."
Philip HO
Global Vaccines Public Affairs
-
"The Alcimed team has allowed us to structure the project appropriately, to plan it in the best possible way, and to make sure that every single step of the project was successful."
Federico Bianco, Head of the Special Care Unit at Chiesi
Chiesi and Alcimed collaborated to assess the care pathway of preterm infants at higher risk of developing chronic respiratory infections later in life.
-
"Together between Alcimed and Nestlé Health Science, we made informed decision on where the best opportunities were and why and how to select the most valuable assets in our investigation."
Bernard Cuenoud, Global Head of Research and Clinical Development at Nestlé Health Science
Nestlé Health Science and Alcimed mapped opportunities in the field of rare diseases with a metabolic and nutritional component, structuring a large volume of scientific data to identify and prioritize the most promising assets for development.
-
"The Alcimed team had values at different levels! You helped us understand that, yes, there are proof and evidence in the literature [...] You've identified some potential private partners that could have value for this project. [...] We were a very good team Alcimed / Sanofi."
Lucie Rochard & Laurent Lebel, Head of Partnerships and Stakeholder Engagement & Alliance Manager for Public Private Partnerships at Sanofi
Sanofi and Alcimed conducted a scientific literature review and identified potential private-sector partners to explore the link between early primary infections and the development of chronic diseases, with the aim of translating this knowledge into prevention or therapy solutions for patients.
-
"Alcimed support has enabled Boehringer Ingelheim to move forward efficiently on several projects in a structured way."
"The Alcimed team’s support has enabled Boehringer Ingelheim to move forward efficiently on several projects in a structured way over the past two years. The Alcimed team brought a good level of strategic thinking, an open-mindedness and a willingness to entertain new ideas. These assets enabled Alcimed to successfully challenge internal teams and co-build solutions with them. In the same way, the creation of the VPH Hub in Lyon, accompanied by many players in the Lyon Healthcare ecosystem, has progressed in a more organized and efficient way thanks to a team that is both structuring, structured, and ... friendly."
Erick LELOUCHE, President Boehringer Ingelheim France
Boehringer Ingelheim and Alcimed supported the creation of the HPV Hub in Lyon by bringing together stakeholders from Lyon's healthcare ecosystem, while also supporting several strategic reflection initiatives to challenge and advance internal teams.
-
"Alcimed's support allowed us to have a perfect alignment between the definition of our strategy and its execution."
"I had the chance to work with the Alcimed team in preparing the launch of our first biosimilar in France. Alcimed's support was particularly valuable as it allowed us to have a perfect alignment between the definition of our strategy and its execution, which ultimately contributed to the success of this launch (our product became market leader 12 months after its launch). Alcimed's approach based on a rigorous methodology and the constant search for innovative solutions also allowed us to reinforce the expertise of our internal teams and to create a positive work dynamic. I hope that I will have other opportunities in the future to work with Alcimed's Healthcare team."
Benoit SLAVICEK, Global VP ExCom member at Mundi Pharma
Mundipharma and Alcimed prepared the launch of the company’s first biosimilar in France by aligning strategic planning with operational execution, contributing to the product’s commercial success as it became the market leader within 12 months.
-
"I really appreciated the execution of the project."
"I recently worked with Alcimed on a project to investigate HCP perception of different future products. I really appreciated the execution of the project on an eye-to-eye level between the teams and the broad language skills and multiculturality in the Alcimed team!"
Dr. Sonja RAUCHSCHWALBE, Vice President Marketing Injectable Drugs at B BRAUN
B. Braun and Alcimed collaborated to assess healthcare professionals' perceptions of products in development and prepare for their market launch.
You have a project?
Join our adventure
Embark on our adventure and join a team of 220 explorers from over 20 different nationalities with degrees from the best international universities, passionate about scientific breakthroughs, technological innovations, international development, and challenges in healthcare and climate.
Want to climb aboard?
Join our adventure
Pour aller plus loin
-
Data - AI
AI in medical imaging, a revolution in medical diagnosis and patient care
Artificial intelligence has made its mark in many specialties, such as medical imaging. But how is AI in medical imaging used, and what are the challenges ahead?
-
Healthcare
5 reasons to focus on patient engagement in R&D: the example of rare diseases
Reason 1: the patients are experts in their disease More than in most fields, rare disease patients occupy a position as “patient expert”, having a unique knowledge of their disease. Directly ...
-
Healthcare
3 tips for building the future care pathway
Emergency room crisis, doctor shortage, ecology... The future care pathways must respond to a variety of challenges. Here are 3 tips to help you build them.